Oculogica

Oculogica

Innovative eye-tracking technology for accurate concussion diagnosis without baseline tests.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

Valuation: €0.0

round
*
N/A

$7.6m

Valuation: $41.0m

Early VC
Total Funding000k
Notes (0)
More about Oculogica
Made with AI
Edit

Oculogica is a pioneering medical device company specializing in concussion diagnosis through advanced eye-tracking technology. The company's flagship product, EyeBOX, is the first FDA-cleared concussion assessment tool that does not require a baseline test, making it a significant breakthrough in the field. Oculogica serves a diverse range of clients, including sports organizations, healthcare providers, and medical professionals, addressing the critical need for objective and accurate concussion diagnostics. Operating in the medical technology market, Oculogica's business model revolves around the sale and distribution of its diagnostic devices, along with providing ongoing technical support and regulatory compliance services. Revenue is generated through direct sales, partnerships, and potentially through licensing agreements. The company's commitment to high standards and continuous improvement ensures that it meets the regulatory requirements and customer expectations effectively.

Keywords: concussion diagnosis, eye-tracking technology, FDA-cleared, medical device, healthcare, sports medicine, objective measures, regulatory compliance, technical support, innovation.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo